1. What Happened? – Q1 2025 Earnings Breakdown
Cosmax NBT reported Q1 2025 revenue of ₩75.7 billion (a slight increase YoY), operating profit of ₩2.5 billion (a significant decrease YoY), and a net loss of ₩1.2 billion (a shift into negative territory). These figures fell significantly short of market projections, with the net loss being particularly alarming.
2. Why Did This Happen? – Analyzing the Underperformance
Key factors contributing to the weak performance include a slowdown in the domestic market, foreign exchange losses due to increased volatility, and rising costs stemming from higher raw material prices. However, continued growth in overseas markets and positive developments such as new dosage form development and securing individually recognized ingredients offer potential upside.
3. What’s Next? – Future Outlook and Investment Strategies
While short-term stock weakness is anticipated, several positive factors remain in play for the mid-to-long term, including overseas market growth, technological competitiveness, and the appointment of a new CEO. Investors should focus on the company’s long-term growth potential rather than short-term stock fluctuations and adopt a cautious investment approach. Key factors to monitor include earnings recovery trends from Q2 onwards, growth rates in overseas markets, and the success of new business ventures.
4. Action Plan for Investors
- Hold: If you currently hold Cosmax NBT stock, maintaining a wait-and-see approach is recommended for the time being.
- New Investment: For those considering new investments, carefully evaluate future earnings recovery, the company’s ability to manage foreign exchange risk, and the realization of new growth momentum before making a decision.
Frequently Asked Questions
Q. Why did Cosmax NBT’s Q1 2025 earnings fall short of expectations?
A. A combination of factors contributed to the underperformance, including a slowdown in the domestic market, foreign exchange losses from increased volatility, and rising raw material prices.
Q. Is Cosmax NBT a good investment?
A. Short-term stock weakness is anticipated. A cautious investment approach is recommended, focusing on the company’s long-term growth potential and closely monitoring earnings recovery trends and growth rates in overseas markets.
Q. What key factors should investors watch for in Cosmax NBT’s future?
A. Investors should monitor earnings recovery from Q2 onwards, overseas market revenue growth rates, commercialization and revenue contribution of new individually recognized ingredients, foreign exchange risk management strategies, and the new CEO’s management strategies.